✦ LIBER ✦

The combination of low dose of naloxone and morphine in patient-controlled (PCA) does not decrease opioid requirements in the postoperative period

✍ Scribed by Donald R Mehlisch

Book ID: 117479077
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 55 KB
Volume: 101
Category: Article
ISSN: 0304-3959
DOI: 10.1016/s0304-3959(02)00352-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The combination of low dose of naloxone

The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period

✍ M.Soledad Cepeda; Juan M Africano; Ana M Manrique; Wilmer Fragoso; Daniel B Carr 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Combination of Low-dose Nalbuphine and M

Combination of Low-dose Nalbuphine and Morphine in Patient-controlled Analgesia Decreases Incidence of Opioid-related Side Effects

✍ Yu-Chang Yeh; Tzu-Fu Lin; Hung-Chi Chang; Wing-Sum Chan; Yong-Ping Wang; Chen-Ju 📂 Article 📅 2009 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 201 KB

Does adding low doses of oral naltrexone

Does adding low doses of oral naltrexone to morphine alter the subsequent opioid requirements and side effects in trauma patients?

✍ Shervin Farahmand; Omid Ahmadi; Ahmadreza Dehpour; Patricia Khashayar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 97 KB

The fixed dose combination of valsartan

The fixed dose combination of valsartan 160/HCTZ 25 in hypertensive patients not controlled by fixed dose combinations of AT1 receptor antagonists and low dose HCTZ

✍ Reinhard Fuenfstueck; Rolf-Dieter Hempel; Anwar Ansari; Gottfried Weidinger; Sve 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Low-dose warfarin does not decrease the

Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin

✍ Amy Lin; Janice Ryu; Danielle Harvey; Barbara Sieracki; Sidney Scudder; Ted Wun 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Trial finds low dose ramipril does not r

Trial finds low dose ramipril does not reduce cardiovascular or renal events in people with type 2 diabetes and albuminuria: Abstracted from: Marre M, Lievre M, Chatellier G, et al. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 2004; 328(7438): 495–500.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB